We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Rj7.5
Royal Jelly Research
Probably helpsModerate safety
35 peer-reviewed studies
What the evidence says
Probably helps
Royal Jelly helped in about half (4/6) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 2007–2026 with a typical study size of 72 participants.
Based on 35 studies · 4 meta-analyses · 24 RCTs · 5,550 total participants
Confidence
High
What the studies found
4helped2unclear· 29 more without graded effect data
By outcome
Women's healthMay help manage menopausal symptoms like hot flashes and mood changes · 4-8 weeks · May help reduce menstrual discomfort and PMS symptoms · 1-3 cycles
Probably helps11 studies
Glucose & metabolic
Mostly mechanism / observational10 studies
Therapeutic & clinical
Mostly mechanism / observational8 studies
Cholesterol & lipids
Mostly mechanism / observational6 studies
Inflammation
Mostly mechanism / observational6 studies
Safety profile
Mostly mechanism / observational4 studies
Heart & blood pressure
Mostly mechanism / observational3 studies
Muscle strength & power
Too few graded studies2 studies
Liver health
Too few graded studies2 studies
Skin health10-HDA and royalactin support collagen production and skin repair · 4-8 weeks
Too few graded studies1 study
Cognitive function
Too few graded studies1 study
Bone health
Too few graded studies1 study
Vision & eye health
Too few graded studies1 study
Men's vitality
Too few graded studies1 study
By the numbers
Pulled from 22 studies with measurable effects
Likely real effects
75%
across studies
People studied
5,550
typical study: 72 people
Strongest designs
28
4 pooled, 24 randomised
Showed benefit
67%
4/6 studies
How long studies ran
1–3 months
3
3+ months
2
Populations Studied
Postmenopausal women4
Healthy volunteers2
Users of apitherapeutic products, particularly atopic individuals1
Breast cancer patients1
Active research area
13 studies in the last 5 years · Latest meta-analysis: 2026
200720162026
1Meta-AnalysisCited 1×n=3,544 · very large study2025
This meta-analysis examined the effects of Propolis.
Norouzzadeh M et al. · Nutrition & diabetes (2025)
Propolis demonstrated reductions in anthropometric measures and improvements in lipid profile, glycemic control, liver enzymes, and inflammation and oxidative stress markers.
While long-term or high-dose honey consumption in individuals with health concerns warrants caution, RJ and propolis demonstrated dose-dependent benefits for cardiometabolic health with proper certainty.
Future research should focus on population-specific characteristics and optimized dosages.
Rocha Filho LKA et al. · Archives of toxicology (2026)
Allergic responses were the most prevalent type of adverse event, particularly among atopic individuals.
These findings highlight the need for appropriate labeling, post-marketing surveillance, and educational campaigns to ensure the safe use of these products.
It is concluded that despite their recognized benefits, apitherapeutic products must be used with caution, and the strengthening of pharmacovigilance systems is essential to safeguard public health.
The large discrepancies and number of different recommendations demonstrate that apitherapy is not a consistent type of medicine.
Münstedt K et al. · Allergologia et immunopathologia (2020)
No clear effect
← WorseNo effectBetter →
Only 38.8% of the apitherapy books mentioned seasonal allergic rhinitis.
The most reasonable recommendation according to clinical studies on the subject, namely the use of a mix of honey and pollen, was only found once (0.8%).
The large discrepancies and number of different recommendations demonstrate that apitherapy is not a consistent type of medicine.
Conclusions: Palifermin, Chlorhexidine, Smecta, Actovegin, Kangfuxin, L. brevis lozenges, Royal jelly, Zync supplement, Benzydamine, cryotherapy, laser therapy and professional oral hygiene may be used in oral mucositis treatment and prevention.
Daugėlaitė G et al. · Medicina (Kaunas, Lithuania) (2019)
It occurs in almost all patients, who receive radiation therapy of the head and neck area and from 20% to 80% of patients who receive chemotherapy.
Preferred reporting items for systematic reviews and meta-analysis (PRISMA) protocol was followed while planning, providing objectives, selecting studies and analyzing data for this systematic review. "MEDLINE" and "PubMed Central" databases were used to search eligible clinical trials.
Clinical trials researching medication, oral hygiene, cryotherapy or laser therapy efficiency in treatment or/and prevention of oral mucositis were included in this systematic review.
Seven studies showed a significant reduction in FBS, and one reported HbA1c decrease following royal jelly supplementation.
Maleki V et al. · Complementary therapies in medicine (2019)
Seven studies showed a significant reduction in FBS, and one reported HbA1c decrease following royal jelly supplementation.
Although royal jelly supplementation resulted in significant reductions in HOM A-I R in three studies, the findings on insulin levels were controversial.
In addition, royal jelly resulted in a decrease oxidative stress indicators and increase antioxidant enzymes levels.
The findings suggest that RJ may help decrease oxidative stress and improve motor function and anti-oxidant capacity in MS patients, potentially slowing disease progression.
Eslamifar Z et al. · Irish journal of medical science (2025)
Results indicated that the RJ group experienced a significant reduction in EDSS scores (P < 0.001) and MDA levels (P < 0.0001).
The findings suggest that RJ may help decrease oxidative stress and improve motor function and anti-oxidant capacity in MS patients, potentially slowing disease progression.
10Vascular endothelial function (RH-PAT index)RCTCited 11×n=100 · medium study2022
Royal jelly might have antiatherogenic property by improving vascular endothelial function.
Fujisue K et al. · Journal of atherosclerosis and thrombosis (2022)
Large benefit
← WorseNo effectBetter →
Likely real
The mean age of the participants was 35.0±9.3 years in the placebo group and 36.1±9.1 years in the royal jelly groups; 45% and 50% of the placebo and the royal jelly groups, respectively, were male.
The percentage relative change in the RH-PAT index was significantly higher in the royal jelly group than in the placebo group (21.4%±53.1% vs. 0.05%±40.9%, P=0.037).
Royal jelly might have antiatherogenic property by improving vascular endothelial function.
11Handgrip strengthRCTCited 19×n=163 · medium study2017
In addition, we have not found that pRJ intervention can achieve improvement or attenuating the decrease in physical performance.
Meng G et al. · Scientific reports (2017)
No clear effect
← WorseNo effectBetter →
Borderline
The dropout rate was 16.0%.
The means (95% confidence interval) of change in handgrip strength for placebo, low-dose, and high-dose groups are -0.98(-2.04,0.08), 0.50(-0.65,1.65) and 1.03(-0.37,2.44) kg (P = 0.06, P for trend = 0.02), respectively.
No significant effects of the interventions were observed for physical performances.
As a result, the study results demonstrate that royal jelly administrated by a certain procedure improved the signs and symptoms of oral mucositis and markedly shortened its healing time.
Erdem O et al. · Holistic nursing practice (2014)
All patients received mouthwash therapy with benzydamine hydrochloride and nystatin rinses.
In addition, patients in the experimental group received royal jelly.
The mean resolution time of oral mucositis in the royal jelly group was significantly shorter than that of the control group.
Lady 4 may be beneficial in the treatment of menopausal syndrome and can be used as a safe natural promoter of health and well-being in women during the menopausal transition.
Yakoot M et al. · Forschende Komplementarmedizin (2006) (2011)
Lady 4 may be beneficial in the treatment of menopausal syndrome and can be used as a safe natural promoter of health and well-being in women during the menopausal transition.
15Cardiovascular parametersRCTCited 13×n=100 · medium study2018
Subjects who received Honey Cocktail showed remarkable effects on body mass index.
Ab Wahab SZ et al. · Complementary therapies in medicine (2018)
Noticeable benefit
← WorseNo effectBetter →
Likely real
There was a significant decrease in the diastolic blood pressure from 77.92 mmHg at baseline to 73.45 mmHg at 12 months (F-statistic = 2.55, p-value = 0.047) in the Tualang Honey group compared to Honey Cocktail.
There was also a significant decrease in the fasting blood sugar from 6.11 mmol/L at baseline to 5.71 mmol/L at 12 months (F-statistic = 4.03, p-value = 0.021) in the Tualang Honey group compared to the Honey Cocktail group.
Subjects who received Honey Cocktail showed remarkable effects on body mass index.
These data suggest that RJ intake may have desirable effects on serum glucose, Apo-A-I concentrations and ApoB/ApoA-I ratios in people with type 2 diabetes.
Khoshpey B et al. · Canadian journal of diabetes (2016)
Noticeable benefit
← WorseNo effectBetter →
Likely real
The mean difference in glucose concentrations decreased in the RJ group (-9.4 mg/dL vs. 4 mg/dL; p=0.011).
The mean difference in ApoA-I concentrations increased in the RJ group (34.4 mg/dL vs. -1.08 mg/dL; p=0.013).
There was a significant decrease in mean difference of ApoB/ApoA-I in the RJ group compared with the placebo group (0.008 vs. 0.13; p<0.044), respectively.
Apitherapy with RJ + GP EPP-AF® extract significantly reduced plasma IL-6 and total cholesterol in HD patients.
Kemp JA et al. · Toxins (2025)
After 2 months, the treated group showed a significant reduction in plasma levels of IL-6 (0.78 to 0.63 pg/mL, p = 0.008) and total cholesterol (138.60 to 111.85 mg/dL, p = 0.03), whereas no changes were observed in the placebo group.
Apitherapy with RJ + GP EPP-AF® extract significantly reduced plasma IL-6 and total cholesterol in HD patients.
This supplementation shows promise as a non-pharmacological strategy to reduce cardiovascular risk markers in this population.
However, in order to obtain more accurate scientific evidence, it is necessary to investigate more doses and timing of royal jelly in future studies.
Askari R et al. · Medicina (Kaunas, Lithuania) (2025)
The results show a significant increase in PON1 (p = 0.008) and HDL (p = 0.005) in the exercise + supplement group compared to the exercise + placebo group.
But significant decreases in oxLDL (p = 0.031), TC (p = 0.045), TG (p = 0.013), LDL (p = 0.027), ALT (p = 0.015) and AST (p = 0.009) were observed in the exercise + supplement group compared to the exercise + placebo group (<0.05).
The results show a significant increase in PON1 (p = 0.008) and HDL (p = 0.005) in the exercise + supplement group compared to the exercise + placebo group.
20PSA scores and IPSS valuesRCTCited 4×n=40 · small study2016
The therapeutical use of RJ exhibited no side effects.
Pajovic B et al. · The aging male : the official journal of the International Society for the Study of the Aging Male (2016)
Since the use of RJ did not lead to any significant reduction in PVR, prostate volume, or to any involution of the transitory zone, it appears that it may only affect the blood marker of prostatic hyperplasia and to improve quality-of-life (QoL) in those patients.
The results of this study confirm the potential of RJ in reducing PSA scores and improving IPSS values.
Overall, in comparison to phytotherapy and conventional therapy, RJ had similar positive effects on QoL in patients with BPH, however it exhibited markedly better effects on reducing PSA levels in blood.